查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933299

全球冠状动脉支架市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Coronary Stent Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 160 Pages | 商品交期: 请询问到货日

价格

冠状动脉支架市场成长驱动因素

2025年全球冠状动脉支架市场规模达到70.2亿美元，并预计从2026年的73.8亿美元成长至2034年的122.6亿美元，2026年至2034年的年复合成长率（CAGR）为6.54%。北美地区在2025年占据市场主导地位，市场占有率达33.55%，这得益于其完善的医疗保健基础设施、冠状动脉疾病（CAD）的高发病率以及监管部门批准推动的频繁产品上市。

冠状动脉支架是一种小型管状装置，插入冠状动脉以保持其畅通。它们主要用于经皮冠状动脉介入治疗（PCI），以治疗动脉粥状硬化等疾病。全球心血管疾病发生率的上升、支架植入技术的进步以及 PCI 手术精准度的提高，推动其在已开发市场和新兴市场的应用。

市场驱动因素

冠状动脉疾病盛行率上升

全球冠状动脉疾病盛行率的上升是推动市场发展的关键因素。导致这现象的因素包括久坐的生活方式、压力和不健康的饮食习惯。根据美国疾病管制与预防中心（CDC）的资料，到2023年，约有 5%的20 岁及以上成年人将患有冠状动脉疾病（CAD），这意味着庞大的患者群体将推动对支架的需求。此外，全球人口老化，老年人更容易患上冠状动脉疾病，这也进一步加速了市场成长。

技术进步

支架设计方面的创新，例如药物洗脱支架（DES）和生物可吸收支架，提高了安全性和临床疗效。Medtronic公司的Onyx Frontier DES（2022年获得 FDA 批准）等器械采用了改进的输送系统，有助于进行复杂的经皮冠状动脉介入治疗（PCI）手术。微创介入、再狭窄率降低以及支架柔软度提高，促使全球心臟科医师日益采用这些器材。

市场限制

副作用与监管障碍

动脉损伤、过敏反应和再狭窄等併发症阻碍了支架的广泛应用。严格的监管审批也限制了某些地区的产品供应。产品召回，例如2022年 Atrium Medical 公司召回的iCast 涂层支架，可能会对患者的信心和市场扩张产生负面影响。

市场机会

在新兴地区，由于人们对心血管疾病的认识不断提高、专科医院的扩建以及导管室的发展，预计将出现显着的成长机会。印度的公共心臟健康运动（2023年）以及澳洲和印度2024年的医院扩建计画表明，医疗服务的可及性和公众意识都在提高，这为支架的普及创造了机会。

市场趋势

冠状动脉支架技术的持续创新（例如，减少支柱厚度、提高柔韧性以及引进生物分解聚合物）推动市场成长。例如，Medinol公司的EluNIR-PERL药物洗脱支架于2023年获得FDA批准，有助于改善患者预后并提高手术效率。

细分市场分析

依支架类型

  • 药物洗脱支架（DES）将主导市场，到2026年将占据 76.51%的市场占有率，这主要得益于监管部门的批准、临床需求以及再狭窄率的下降。雅培的XIENCE Sierra DES 于2024年在印度上市，正是此一趋势的典型代表。
  • 裸金属支架由于适用于出血风险高的患者，因此保持适度成长。
  • 生物可吸收支架的市场扩张，这主要归因于人口老化和慢性心血管疾病的增加。
  • 覆膜支架市场成长，这主要得益于 BIOTRONIK 于2019年推出的用于紧急穿孔治疗的PK Papyrus 等产品。

依材料分类

  • 金属支架（不锈钢、钴铬合金和铂铬合金）将在2024年占据市场主导地位，并有望凭藉其高效性和耐用性保持领先地位。
  • 用于生物可吸收装置的聚合物支架也因其临床优势而有望成长。

依置入方式分类

  • 自膨式支架将在2026年占据69.11%的市场占有率，展现出较高的临床疗效。
  • 球囊扩张式支架将因技术进步和经皮冠状动脉介入治疗（PCI）的广泛应用而保持稳定成长。

依应用领域

  • 到2026年，慢性冠状动脉症候群（CCS）将占据89.21%的市场占有率，这反映了冠状动脉疾病（CAD）的高发生率。
  • 急性冠状动脉症候群（ACS）领域成长，这主要得益于急性病例经皮冠状动脉介入治疗（PCI）手术量的增加。

依最终使用者

  • 医院和门诊手术中心（ASC）是市场的主要驱动力，这得益于其高手术量、先进的基础设施以及新建心臟护理机构（例如，美国弗吉尼亚州，2024年）。
  • 专科诊所的成长较为温和，这主要得益于心臟科医师网路的扩展和病患意识的提高。
  • 其他机构（例如导管室）也在稳定扩张。

依地区划分的预测

  • 北美：到2025年，市场规模达到23.5亿美元，主要得益于先进的基础设施和冠状动脉疾病（CAD）的高发病率。
  • 欧洲：预期成长温和。预计到2026年，英国和德国的市场规模将分别达到5.1亿美元和6.4亿美元。
  • 亚太地区：预计成长迅速。预计到2026年，日本市场规模将达到2.5亿美元，中国将达到3.9亿美元，印度将达到3.3亿美元，主要得益于医院的扩建和新型支架的上市（例如，Terumo的Ultimaster Nagomi支架计划于2023年在印度上市）。
  • 拉丁美洲、中东和非洲：由于冠状动脉疾病病例和血管成形术的增加，预计市场将保持稳定成长。

依支架种类：药物洗脱支架

  • 覆膜支架
  • 裸金属支架
  • 生物可吸收支架
  • 其他（双效治疗支架）

依材质：金属

  • 聚合物

依置入方式*：自膨式

  • 球囊扩张式

依用途：急性冠状动脉疾病/冠状动脉症候群（ACS）

  • 慢性冠状动脉症候群（CCS）

依最终使用者：医院和门诊手术中心（ASC）

  • 专科诊所
  • 其他

依地区：北美（支架类型、材料类型、植入方法、应用、最终用户、国家）

  • 美国
  • 加拿大
  • 欧洲（依支架类型、材料类型、植入方法、应用、最终用户和国家划分））
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区
  • 亚太地区（依支架类型、材料类型、植入方法、应用、最终用户和国家划分）
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 东南亚
    • 亚太其他地区
  • 拉丁美洲（依支架类型、材料类型、植入方法、应用、最终用户及国家）
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲（依支架类型、材料类型、植入方式、应用、最终用户及国家划分）
    • GCC国家
    • 南非
    • 中东和非洲其他地区

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要国家和地区冠状动脉疾病（CAD）盛行率（2023/2025）
  • 冠状动脉支架技术进展
  • 主要厂商新产品发布
  • 主要产业趋势：併购、业务合作等
  • 新冠疫情对市场的影响

第5章 全球冠状动脉支架市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依支架类型划分
    • 药物洗脱支架
    • 覆膜支架
    • 裸金属支架
    • 生物可吸收支架
    • 其他
  • 市场分析、洞察与预测：依材料类型划分
    • 金属
    • 聚合物
  • 市场分析、洞察与预测：以植入方式划分
    • 自膨式支架
    • 球囊扩张式支架
  • 市场分析、洞察与预测：依应用划分
    • 急性冠状动脉症候群（ACS）
    • 慢性冠状动脉症候群（CCS）
  • 市场分析、洞察与预测：依最终用户划分
    • 医院和门诊手术中心（ASC）
    • 专科诊所
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北部美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美冠状动脉支架市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲冠状动脉支架市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 其他欧洲国家

第8章 亚太地区冠状动脉支架市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲冠状动脉支架市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第10章 中东与非洲冠状动脉支架市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC国家
    • 南亚非洲
    • 其他中东和非洲地区

第11章 竞争分析

  • 全球市场占有率分析（2025年）
  • 公司简介
  • Medtronic
  • Boston Scientific Corporation
  • BIOTRONIK SE &Co. KG
  • Terumo Corporation
  • Abbott
  • Relisys Medical Devices Limited.
  • B. Braun SE
  • MicroPort Scientific Corporation
  • Stentys S.A.
  • Meril Life Sciences Pvt. Ltd.
Product Code: FBI100065

Growth Factors of coronary stents Market

The global coronary stents market was valued at USD 7.02 billion in 2025 and is projected to grow from USD 7.38 billion in 2026 to USD 12.26 billion by 2034, registering a CAGR of 6.54% during 2026-2034. North America dominated the market in 2025 with a 33.55% share, supported by robust healthcare infrastructure, high prevalence of coronary artery diseases (CAD), and frequent product launches backed by regulatory approvals.

Coronary stents are small, tube-shaped devices inserted into coronary arteries to keep them open, primarily used in Percutaneous Coronary Interventions (PCI) to treat conditions like atherosclerosis. The rising global incidence of cardiovascular diseases, technological advancements in stenting procedures, and improved accuracy in PCI operations are driving adoption in both developed and emerging markets.

MARKET DRIVERS

Rising Prevalence of Coronary Heart Disease

The growing prevalence of coronary heart disorders globally is a key market driver. Sedentary lifestyles, stress, and unhealthy eating habits are contributing factors. According to the U.S. CDC, about 5% of adults aged 20+ had CAD in 2023, highlighting a significant patient pool driving demand for stents. Additionally, the aging global population, more prone to CAD, further propels market growth.

Technological Advancements

Innovations in stent design, such as drug-eluting stents (DES) and bioresorbable stents, have enhanced safety and clinical outcomes. Devices like Medtronic's Onyx Frontier DES (FDA approved in 2022) feature improved delivery systems, facilitating complex PCI procedures. Minimally invasive interventions, reduced restenosis rates, and enhanced stent flexibility are increasing adoption among cardiologists worldwide.

MARKET RESTRAINTS

Side Effects and Regulatory Barriers

Complications like arterial damage, allergic reactions, or restenosis can hinder adoption. Strict regulatory approvals also limit product entry in certain regions. Product recalls, such as Atrium Medical's iCast-covered stents in 2022, negatively impact patient trust and market expansion.

MARKET OPPORTUNITIES

Emerging regions present significant growth potential due to rising awareness of cardiovascular diseases, expansion of specialty hospitals, and establishment of catheterization labs. Initiatives like India's public heart health campaigns (2023) and hospital expansions in Australia and India in 2024 demonstrate increasing accessibility and awareness, creating opportunities for stent adoption.

MARKET TRENDS

Continuous innovations in coronary stents, including reducing strut thickness, improving flexibility, and introducing biodegradable polymers, are shaping market growth. Examples include Medinol's EluNIR-PERL DES, FDA approved in 2023, enhancing patient outcomes and procedural efficiency.

SEGMENTATION ANALYSIS

By Stent Type

  • Drug-eluting stents (DES) dominate with 76.51% market share in 2026, driven by regulatory approvals, clinical demand, and reduced restenosis rates. Abbott's XIENCE Sierra DES launched in India in 2024 exemplifies this trend.
  • Bare metal stents maintain moderate growth due to suitability in high-bleeding-risk patients.
  • Bioresorbable stents are expanding due to increasing elderly populations and chronic cardiovascular conditions.
  • Covered stents grow via product launches like BIOTRONIK's PK Papyrus in 2019 for emergency perforation treatments.

By Material

  • Metal-based stents (stainless steel, cobalt-chromium, platinum-chromium) dominate in 2024 and are projected to continue leading due to efficiency and durability.
  • Polymer-based stents (used in bioresorbable devices) are also witnessing growth due to clinical benefits.

By Deployment

  • Self-expandable stents accounted for 69.11% share in 2026, offering high clinical efficiency.
  • Balloon-expandable stents maintain stable growth, benefiting from technological enhancements and PCI procedures.

By Application

  • Chronic Coronary Syndrome (CCS) dominated in 2026 with 89.21% share, reflecting high CAD prevalence.
  • Acute Coronary Syndrome (ACS) segment grows due to rising PCI procedures for acute events.

By End-User

  • Hospitals & Ambulatory Surgical Centers (ASCs) dominate due to high procedure volumes, advanced infrastructure, and opening of new cardiac care facilities (e.g., Virginia, U.S., 2024).
  • Specialty clinics show moderate growth, fueled by increasing cardiologist networks and patient awareness.
  • Others (catheterization labs) are steadily expanding.

REGIONAL OUTLOOK

  • North America: USD 2.35 billion in 2025, dominating due to advanced infrastructure and high CAD prevalence.
  • Europe: Moderate growth; UK USD 0.51 billion and Germany USD 0.64 billion in 2026.
  • Asia Pacific: Rapid growth; Japan USD 0.25 billion, China USD 0.39 billion, India USD 0.33 billion in 2026, driven by hospital expansions and new stent launches (Terumo Ultimaster Nagomi in India, 2023).
  • Latin America & Middle East & Africa: Steady growth due to rising CAD cases and angioplasty procedures.

COMPETITIVE LANDSCAPE

Key players include Abbott, Medtronic, Boston Scientific, BIOTRONIK, Terumo, MicroPort, B. Braun SE, Stentys, Meril Life Sciences, and Relisys Medical. Strategic acquisitions, regulatory approvals, and clinical trials are the primary growth strategies. Notable developments: Abbott acquiring CSI in 2023 and MicroPort receiving NMPA approval for Firesorb in 2024.

CONCLUSION

The global coronary stents market is projected to grow steadily from USD 7.02 billion in 2025 to USD 12.26 billion by 2034, driven by rising CAD prevalence, technological advancements in stent design, and expansion of healthcare infrastructure worldwide. While procedural risks, regulatory barriers, and product recalls pose challenges, innovations such as drug-eluting, bioresorbable, and self-expandable stents, coupled with emerging regional opportunities, ensure a robust growth trajectory. North America maintains dominance, while Asia Pacific exhibits the highest growth potential, creating significant opportunities for both established and emerging market players.

Segmentation Stent Type, Material Type, Deployment, Application, End-user, and Region

By Stent Type * Drug Eluting Stent

  • Covered Stent
  • Bare Metal Stent
  • Bioresorbable Stent
  • Others (Dual Therapy Stents)

By Material Type * Metal

  • Polymer

By Deployment * Self-expandable

  • Balloon-expandable

By Application * Acute Coronary Syndrome (ACS)

  • Chronic Coronary Syndrome (CCS)

By End-user * Hospitals & ASCs

  • Specialty Clinics
  • Others

By Region * North America (By Stent Type, Material Type, Deployment, Application, End-user, and Country)

    • U.S.
    • Canada
  • Europe (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Stent Type, Material Type, Deployment, Application, End-user, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Coronary Artery Disease (CAD), by Key countries/sub-region, 2023/2025
  • 4.2. Technological Advancements in Coronary Stents
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Stent Type
    • 5.1.1. Drug Eluting Stent
    • 5.1.2. Covered Stent
    • 5.1.3. Bare Metal Stent
    • 5.1.4. Bioresorbable Stent
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Material Type
    • 5.2.1. Metal
    • 5.2.2. Polymer
  • 5.3. Market Analysis, Insights and Forecast - By Deployment
    • 5.3.1. Self-expandable
    • 5.3.2. Balloon-expandable
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Acute Coronary Syndrome (ACS)
    • 5.4.2. Chronic Coronary Syndrome (CCS)
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Hospitals & ASCs
    • 5.5.2. Specialty Clinics
    • 5.5.3. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Stent Type
    • 6.1.1. Drug Eluting Stent
    • 6.1.2. Covered Stent
    • 6.1.3. Bare Metal Stent
    • 6.1.4. Bioresorbable Stent
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Material Type
    • 6.2.1. Metal
    • 6.2.2. Polymer
  • 6.3. Market Analysis, Insights and Forecast - By Deployment
    • 6.3.1. Self-expandable
    • 6.3.2. Balloon-expandable
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Acute Coronary Syndrome (ACS)
    • 6.4.2. Chronic Coronary Syndrome (CCS)
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Hospitals & ASCs
    • 6.5.2. Specialty Clinics
    • 6.5.3. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Stent Type
    • 7.1.1. Drug Eluting Stent
    • 7.1.2. Covered Stent
    • 7.1.3. Bare Metal Stent
    • 7.1.4. Bioresorbable Stent
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Material Type
    • 7.2.1. Metal
    • 7.2.2. Polymer
  • 7.3. Market Analysis, Insights and Forecast - By Deployment
    • 7.3.1. Self-expandable
    • 7.3.2. Balloon-expandable
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Acute Coronary Syndrome (ACS)
    • 7.4.2. Chronic Coronary Syndrome (CCS)
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Hospitals & ASCs
    • 7.5.2. Specialty Clinics
    • 7.5.3. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.6.1. Germany
    • 7.6.2. U.K.
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Stent Type
    • 8.1.1. Drug Eluting Stent
    • 8.1.2. Covered Stent
    • 8.1.3. Bare Metal Stent
    • 8.1.4. Bioresorbable Stent
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Material Type
    • 8.2.1. Metal
    • 8.2.2. Polymer
  • 8.3. Market Analysis, Insights and Forecast - By Deployment
    • 8.3.1. Self-expandable
    • 8.3.2. Balloon-expandable
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Acute Coronary Syndrome (ACS)
    • 8.4.2. Chronic Coronary Syndrome (CCS)
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Hospitals & ASCs
    • 8.5.2. Specialty Clinics
    • 8.5.3. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Stent Type
    • 9.1.1. Drug Eluting Stent
    • 9.1.2. Covered Stent
    • 9.1.3. Bare Metal Stent
    • 9.1.4. Bioresorbable Stent
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Material Type
    • 9.2.1. Metal
    • 9.2.2. Polymer
  • 9.3. Market Analysis, Insights and Forecast - By Deployment
    • 9.3.1. Self-expandable
    • 9.3.2. Balloon-expandable
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Acute Coronary Syndrome (ACS)
    • 9.4.2. Chronic Coronary Syndrome (CCS)
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Hospitals & ASCs
    • 9.5.2. Specialty Clinics
    • 9.5.3. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Coronary Stents Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Stent Type
    • 10.1.1. Drug Eluting Stent
    • 10.1.2. Covered Stent
    • 10.1.3. Bare Metal Stent
    • 10.1.4. Bioresorbable Stent
    • 10.1.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Material Type
    • 10.2.1. Metal
    • 10.2.2. Polymer
  • 10.3. Market Analysis, Insights and Forecast - By Deployment
    • 10.3.1. Self-expandable
    • 10.3.2. Balloon-expandable
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Acute Coronary Syndrome (ACS)
    • 10.4.2. Chronic Coronary Syndrome (CCS)
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Hospitals & ASCs
    • 10.5.2. Specialty Clinics
    • 10.5.3. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, Financials (based on availability), Recent Developments, Strategies, SWOT, Etc.)
    • 11.2.1. Medtronic
    • 11.2.2. Boston Scientific Corporation
    • 11.2.3. BIOTRONIK SE & Co. KG
    • 11.2.4. Terumo Corporation
    • 11.2.5. Abbott
    • 11.2.6. Relisys Medical Devices Limited.
    • 11.2.7. B. Braun SE
    • 11.2.8. MicroPort Scientific Corporation
    • 11.2.9. Stentys S.A.
    • 11.2.10. Meril Life Sciences Pvt. Ltd.

List of Tables

  • Table 1: Global Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 2: Global Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 3: Global Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 4: Global Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Coronary Stents Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 8: North America Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 9: North America Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 10: North America Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Coronary Stents Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 14: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 15: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 16: Europe Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 20: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 21: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 22: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 26: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 27: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 28: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Latin America Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Stent Type, 2021-2034
  • Table 32: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Material Type, 2021-2034
  • Table 33: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Deployment, 2021-2034
  • Table 34: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Coronary Stents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Coronary Stents Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Coronary Stents Market Value Share (%), by Stent Type, 2025 & 2034
  • Figure 3: Global Coronary Stents Market Value Share (%), by Material Type, 2025 & 2034
  • Figure 4: Global Coronary Stents Market Value Share (%), by Deployment, 2025 & 2034
  • Figure 5: Global Coronary Stents Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global Coronary Stents Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global Coronary Stents Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 9: North America Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 10: North America Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 11: North America Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 12: North America Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 13: North America Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 14: North America Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 15: North America Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 16: North America Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 17: North America Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 18: North America Coronary Stents Market Value (USD billion), by Country, 2025 & 2034
  • Figure 19: North America Coronary Stents Market Value Share (%), by Country, 2025
  • Figure 20: Europe Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 21: Europe Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 22: Europe Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 23: Europe Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 24: Europe Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 25: Europe Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 26: Europe Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27: Europe Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 28: Europe Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29: Europe Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 30: Europe Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 31: Europe Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 32: Asia Pacific Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 33: Asia Pacific Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 34: Asia Pacific Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 35: Asia Pacific Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 36: Asia Pacific Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 37: Asia Pacific Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 38: Asia Pacific Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39: Asia Pacific Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 40: Asia Pacific Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 44: Latin America Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 45: Latin America Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 46: Latin America Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 47: Latin America Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 48: Latin America Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 49: Latin America Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 50: Latin America Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 51: Latin America Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 52: Latin America Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 53: Latin America Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 56: Middle East & Africa Coronary Stents Market Value (USD billion), by Stent Type, 2025 & 2034
  • Figure 57: Middle East & Africa Coronary Stents Market Value Share (%), by Stent Type, 2025
  • Figure 58: Middle East & Africa Coronary Stents Market Value (USD billion), by Material Type, 2025 & 2034
  • Figure 59: Middle East & Africa Coronary Stents Market Value Share (%), by Material Type, 2025
  • Figure 60: Middle East & Africa Coronary Stents Market Value (USD billion), by Deployment, 2025 & 2034
  • Figure 61: Middle East & Africa Coronary Stents Market Value Share (%), by Deployment, 2025
  • Figure 62: Middle East & Africa Coronary Stents Market Value (USD billion), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa Coronary Stents Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa Coronary Stents Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 65: Middle East & Africa Coronary Stents Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East & Africa Coronary Stents Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Coronary Stents Market Value Share (%), by Country/Sub-region, 2025
  • Figure 68: Global Coronary Stents Market Share (%), By Company, 2025